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Abstract : Background : Systemic chemotherapy can drastically downsize metastatic liver tumors and these 
small liver lesions could sometimes be difficult for surgeons to detect during hepatectomy. We assessed the use-
fulness of intraoperative real-time virtual sonography (RVS) with contrast-enhanced ultrasonography (CEUS) 
using ‘Sonazoid’ contrast agent (RVS-CEUS). Methods : We performed the intraoperative RVS-CEUS technique 
on 10 tumor lesions in six cases, which were scheduled for hepatic resection of < 10 mm in diameter in our liver 
metastases series. These lesions were preoperatively diagnosed by contrast enhanced-computed tomography 
(CE-CT) or Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic 
resonance imaging (EOB-MRI). We assessed the detectability of a tumor with RVS-CEUS during surgery and 
compared it with that of preoperative CE-CT or EOB-MRI. Results : Detectability of RVS-CEUS for 10 small le-
sions was 90% (n = 9/10) and that of other preoperative modalities were 50% (n = 5/10, CE-CT) and 100% (n = 10/10, 
EOB-MRI). Minimum tumor size detected was 3.0 mm in diameter, and maximum depth of detection with RVS-
CEUS was 43.5 mm ; these results could be an advantage when compared with other intraoperative diagnostic 
modalities. Conclusion : Intraoperative RVS-CEUS was useful for detecting small metastatic liver lesions after 
chemotherapy and could be an effective intraoperative diagnostic technique for hepatic resection of a size < 10 
mm. J. Med. Invest. 66 : 319-323, August, 2019
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INTRODUCTION
 
Since considerable advancements have been made in systemic 
chemotherapies for the treatment of colorectal cancer, aggres-
sive surgical resection combined with systemic chemotherapy 
for colorectal liver metastases (CRLM) has become a standard 
treatment (1). These chemotherapies can reduce the tumor size of 
CRLM, allowing radical resection unless tumors were initially 
unresectable (2, 3). Several reports described that the incidence 
of ‘disappearing’ liver metastases (DLM) in patients receiving 
preoperative systemic chemotherapy ranged from 7-37% (4-6). 
The phenomenon of disappearing small liver metastases seems 
to be a radiological rather than an actual biological occurrence, 
because the rates of macroscopic and microscopic residual dis-
ease are high and the local recurrence rates are high as well 
(7). Therefore, surgeons must detect these downsized and small 
lesions of metastatic liver tumors accurately during surgery for 
radical resection.
Preoperative imaging for the diagnosis of hepatic lesions has 
been extremely developed with the advent of contrast-enhanced 
ultrasonography (CEUS) and Gadolinium-ethoxybenzyl-dieth-
ylenetriamine pentaacetic acid-enhanced magnetic resonance 
(MR) images (EOB-MRI). Ultrasoundcontrast microbubbles 
(MBs), such as Sonazoid MBs, make it possible to render a spe-
cific phase caused by phagocytosis of Sonazoid MBs by Kuppfer 
cells as late vascular phase (8). Gd-EOB-DTPA, which is taken 
up by hepatocytes and excreted in the bile, can make it easy 
to improve the detection and characterization of small hepatic 
tumors (9-11). Using these new modalities, hepatic lesions of a 
few millimeters in size could be detected. However, these small 
hepatic lesions are often difficult to detect using intraoperative 
ultrasound (IOUS) during surgery, because of the dissociation 
between images and intraoperative real-vision of the liver.
Real-time virtual sonography (RVS), also known as real-time 
fusion imaging (Fusion Imaging), is an innovative technique 
that can visualize both scanned ultrasound images and recon-
struction images of computed tomography (CT) and/or magnetic 
resonance (MR) on the same screen of the ultrasound system. 
This imaging technique has already been applied for navigation, 
to guide needle puncture in radiofrequency ablation therapy 
(12), prostate biopsy (13), and identification of breast lesions (14). 
From these facts, we applied the RVS system and CEUS technol-
ogy (RVS-CEUS) for intraoperative use in hepatic resection. In 
this article, we report the significance of RVS-CEUS in detect-
ing small liver lesions as a novel technique in hepatic resection. 
METHODS
Patients and Inclusion criteria
From June 2016 to December 2018, the RVS-CEUS method 
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was indicated in six cases of hepatic resection, which included 
10 liver lesions, at the Gunma University Hospital. The patients 
were selected as follows : malignant hepatic lesions scheduled 
for liver resection ; small lesion less than 10 millimeters ; both 
dynamic CT and EOB-MRI performed preoperatively ; lesion ex-
pected to be very difficult to detect intraoperatively by surgeons ; 
and anticipated curative resection of the liver lesions by hepatic 
resection. The patient characteristics are shown in Table 1. Our 
institutional ethics committee approved the study protocol (Ap-
proval No. : 2018-247). 
Preoperative imaging analysis
Routinely, we reconstruct virtual reality images from CT 
images using SYNAPSE VINCENT software (Fujifilm medical, 
Tokyo, Japan) for preoperative three-dimensional (3D) simula-
tion of hepatic resection. To prepare for using the intraopera-
tive RVS method, preoperative CT or MRI images and digital 
imaging and communication in medicine (DICOM) data were 
uploaded to the RVS ultrasound system before surgery, and we 
reconstructed real-time fusion imaging on the monitor of the 
RVS ultrasound system during surgery (the operative procedure 
is described below).
Procedural steps of RVS technique and Sonazoid enhancement 
For the RVS technique, we used the APLIO i800 system 
(Toshiba Medical Systems Corp., Otawara, Japan). The proce-
dural steps of IO-RVS were as follows : RVS ultrasound system 
was placed on the left side of the patient’s head. The electro-
magnetic transmitter/receiver, which is connected to the RVS 
ultrasound system, was placed on the left side of the patient’s 
neck. The convex type of IOUS probe was attached to the steril-
ized magnetic sensor. This electromagnetic transmitter and the 
sensor detect the spatial position and direction of the ultrasound 
probe using a magnetic field. Then, the spatial positions of both 
the ultrasound and CT/MR images were adjusted appropriately. 
The axial plane of CT/MR images was screened with landmarks 
of the liver such as the portal and hepatic veins for adjustment. 
Next, the probe was placed on the liver surface to adjust fusion 
visualization between the ultrasound image and CT/MR images. 
When the ultrasound probe was moved on surface of the liver, 
real-time multiplanar reconstruction (MPR) images of CT/MR 
could be visualized intraoperatively in the RVS system (Fig. 1A). 
The procedural steps of Sonazoid enhancement were as fol-
lows : after preparation of the RVS system, the ultrasound probe 
was put around the target lesion on the surface of the liver with 
reference to preoperative 3D simulation images. The 0.5 ml 
solution of Sonazoid MBs was injected into the patients intrave-
nously, and then we observed and detected target lesions with 
the ultrasound system. Metastatic tumors are almost visualized 
as low echoic lesions in late vascular phase, which is after five-
to-ten minutes after injection of Sonazoid MBs. The APLIO i800 
system is able to visualize both the Sonazoid-enhanced ultra-
sound image and the RVS image on the same monitor (Fig. 1B).
Statistical analysis
Continuous data are presented as mean (standard deviation 
[SD]) and median (range). Differences between the two cohorts 
were assessed using Fisher’s exact test and the Mann–Whitney 
U test, as appropriate. All statistical analyses were performed 
using SPSS Statistics software version 24.0 (IBM SPSS Inc., 
Chicago, IL). P < 0.05 was considered statistically significant.
RESULTS
The results of the study are summarized in Table 1. All of 
the target lesions were from six cases and 10 lesions (n = 10) 
of metastatic liver tumors, which were derived from patients 
with colorectal cancer (n = 5), and adenosquamous carcinoma 
of the uterus (n = 1). The regimens of chemotherapy were as fol-
lows : XELOX base (n = 3), FOLFOX base Bevacizumab (n = 1), 
and paclitaxel + CDDP (n = 1). Macroscopic pathological findings 
of the liver were revealed in three cases with a normal liver, 
two with a steatotic liver, and one with a blue liver. Microscopic 

































2 2 54 F CRLM 6 4.5 0 XELOX steatotic liver
large fat 
droplet − + +
3 6 4.0 7.3 − + +
4 8 4.6 11.6 + + +
3 5 52 M CRLM 5 4.8 20.0 XELOX+Bev normal normal + + +









droplet − + +
7 7 6.2 21.4 − + −
5 8 65 M CRLM 5/6 4.0 3.0 FOLFOX blue liver sinusoidal obstruction + + +
9 7 7.0 17.6 + + +
6 10 51 M CRLM 5 3.0 0 XELOX+Bev normal normal − + +
RVS, real-time virtual sonography ; CE-CT, contrast-enhanced-computed tomography ; EOB-MRI, gadolinium-ethoxybenzyl-dieth-
ylene-triaminepentaacetic acid-enhanced magnetic resonance image ; RVS-CEUS, contrast-enhanced ultrasonography with real-time 
virtual sonography ; CRLM, Colorectal liver metastases ; Bev, Bevacizumab
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pathological findings were revealed in the post-chemotherapy 
state, shown as large fat droplet (n = 2), and sinusoidal obstruc-
tion (n = 1).
The locations of target lesions were segment 3, 5, 6, 7, and 8, 
respectively (Table 1). Depth of tumors from the liver surface 
ranged from 0.5 to 43.5 mm. The maximum depth of detected 
lesions was 43.5 mm, which indicates that this method has an 
advantage for detecting deep lesions (Fig. 2A, 2B). The mini-
mum size of a liver lesion that could be detected with RVS with 
Sonazoid enhancement was 3.0 mm in diameter in Case No.6. 
The usefulness of the system was limited in cases where the le-
sion existed in the subphrenic portion (segment 7 and 8) near the 
root of the hepatic veins into the inferior vena cava, because the 
ultrasound probe could not be inserted into this space. However, 
some lesions located in segment 7 and 8 could be detected with 
RVS-CEUS (Fig. 2C, 2D). There were no severe postoperative 
complications (Clavien-Dindo classification : grade III or more) 
or any mortality in the patients.
Ten of eleven tumors scheduled for resection were successfully 
identified by this system ; the detection rate was 90% (Table 
2). Of these, one liver tumor located in S7 (case No.4, tumor 
No.7) was difficult to visualize clearly with the RVS system. 
The tumor was located in the dorsal part of segment 7 ; hence, 
the convex probe of RVS was difficult to insert into the dorsal 
space of the right lobe and attach to the liver surface on the pos-
terior side. Detectability of each modality shown in Table 2, re-




In this article, we described a novel technique using RVS with 
Sonazoid enhancement for the detection of small liver lesions, 
which are less than 10 mm in size, diagnosed by preoperative 
imaging such as multidetector CT or EOB-MRI. In the era of 
EOB-MRI and CEUS, small liver lesions downsized a few mil-
limeters after chemotherapy are often detected with these new 
modalities preoperatively. Therefore, hepatobiliary surgeons 
sometimes recognize these small lesions for hepatic resection 
during surgery, and sometimes find it very difficult to detect 
them intraoperatively with the existing traditional modalities 
such as the normal ultrasound. Arita et al. reported the useful-
ness of IO-CEUS in identifying disappearing liver metastases 
from colorectal cancer after chemotherapy (15). For intraopera-
tive diagnosis of liver lesions, IO-CEUS with Sonazoid enhance-
ment has the highest detection rate (sensitivity) and may be the 
most variable modality. This RVS with CEUS method can add to 
the position or recognition diagnostic ability of IO-CEUS. To our 
knowledge, this is a novel report about intraoperative RVS using 
CEUS (Sonazoid enhancement) for hepatic resection.
Figure 1.　Image references of the RVS system. A: RVS image adjusting spatial positions of both ultrasound and CT 
image. The left side of the monitor indicates a CT image and the right side of the monitor indicates an ultrasound im-
age. B: RVS image using Sonazoid enhancement for the liver tumor located on segment 8. The left side of the monitor 
indicates a fusion imaging of the hepatobiliary phase in EOB-MRI, and right side of the monitor indicates Sonazoid 
enhancement. RVS, real-time virtual sonography; CT, computed tomography; EOB-MRI, gadolinium-ethoxybenzyl-di-
ethylene-triaminepentaacetic acid-enhanced magnetic resonance image. 
Figure 2.　A : A liver lesion of segment 7 detected in the hepatobi-
liary phase by EOB-MRI in case No.1 (tumor No.1). The tumor size 
was 5.0 mm in diameter (arrow). B : Macroscopic finding of surgical 
specimen of the liver tumor (arrowhead). C : A liver lesion of segment 
7 detected in the hepatobiliary phase by EOB-MRI in case No.5 (tumor 
No.9). The tumor size was 6.2 mm in diameter (arrow). D : Macro-
scopic finding of surgical specimen of the liver tumor (arrowhead). 
EOB-MRI, gadolinium-ethoxybenzyl-diethylene-triaminepentaacetic 
acid-enhanced magnetic resonance image. 
Table 2.　Detectability of imaging modalities for liver metastatic 
tumors
Modality CE-CT EOB-MRI RVS-CEUS
Detectability, number (%) 5/10 (50%) 10/10 (100%) 9/10 (90%)
CE-CT, contrast-enhanced computed tomography ; EOB-MRI, 
gadolinium-ethoxybenzyl-diethylene-triaminepentaacetic acid-en-
hanced magnetic resonance image ; RVS-CEUS, contrast-en-
hanced ultrasonography with real-time virtual sonography
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Previously, very few technical papers about RVS for hepatic 
resection were reported. Kasuya et al. described that RVS with 
indocyanine green (ICG) fluorescence navigation was useful 
for resecting US invisible liver tumors (16). ICG fluorescence 
navigation is an excellent surgical navigation method utilizing 
the rapid binding of ICG to plasma protein in vivo and the incor-
poration of most ICG into hepatic parenchymal cells. However, 
the detection of liver tumors with ICG fluorescence imaging 
could be indicated for only superficial liver lesions, because 
the excitation light of ICG fluorescence does not reach the deep 
layer of the liver. In this study, we could detect a tumor of 43.5 
mm maximum depth from the liver surface ; that depth is only 
dependent on the ability of the ultrasound system with Sonazoid 
enhancement. Satou et al. reported the usefulness of an RVS 
system combined with preoperative 3D simulation images to 
navigate the detection of tumors and for navigation of the resec-
tion plane for hepatic resection (17). This system may be very 
useful for intraoperative tumor detection and recognition of liver 
anatomy in hepatic resection. Since this system was not used 
with CEUS technique such as RVS with Sonazoid enhancement, 
small isoechoic tumors may not be visualized on the ultrasound 
monitor as a real-time reference image. We believe that the 
ultrasound reference image on the monitor should visualize 
the target tumor for precise guiding of transection plane, which 
leads to radical resection. From the advantage of our RVS with 
CEUS method and the result of this study, when the target liver 
lesion is very small with a size less than 10 mm, we prefer this 
RVS system with CEUS for the surgery.
This method has a few limitations. In cases of the lesion 
located in the subphrenic, posterior, or caudate segments, the ul-
trasound probe could not be inserted into the space, because the 
convex type probe is only available for RVS technology at pres-
ent. In such cases where the lesion is located in these segments, 
it is difficult to reconstruct the fusion image on the monitor. 
Additionally, the lesion located in very right-posterior side need 
to mobilize the right lobe of the liver to attach the ultrasound 
probe. During liver mobilization, the liver is transformed to a 
different form from the preoperative imaging. Therefore, it is 
too difficult to merge the ultrasound images of liver mobilization 
and CT/MRI images together in RVS system. In the future, it is 
expected that a smaller ultrasound probe compatible with both 
RVS and MBs enhancement would be developed, and this probe 
would make it possible to use this method for difficult situations.
Recently, several intraoperative navigation technologies for 
liver surgery have been reported, e.g. 3D printed liver models, 
augmented reality by projection mapping technology, and so on. 
The usefulness of 3D printed synthetic liver has been reported in 
liver surgery fields such as hepatic resection, liver transplanta-
tion, and resection perihilar cholangiocarcinoma (18-21). Having 
the physical model during operations provides greater intuitive 
navigation for critical areas, and this helps to overcome difficult 
orientation because these models can be physically positioned 
in the most desired fashion (19). Igami et al. reported that 3D 
printed liver could be useful in hepatic resection for small tumors 
that are invisible by intraoperative ultrasonography (18). They 
described that there are some disadvantages of 3D printing tech-
nology, such as requirement of long time to print 3D liver models 
and high cost of production. Augmented reality with projection 
mapping technology could also be a promising navigation tool for 
the detection of small tumors in liver surgery. Ntourakis et al. re-
ported that augmented reality might be a helpful navigation tool 
for the resection of small liver metastases that have been shrunk 
by preoperative chemotherapy (22). These technologies are esti-
mated with virtual reconstruction from preoperative images, so 
surgeons should consider accuracy and that errors of a few mil-
limeters may occur during virtual reconstruction. Our strategy 
of this study is presented tumor detection by the real existence 
diagnosis using Sonazoid-enhancing ultrasound. Therefore, this 
method may minimize the error between visualization with RVS 
system and real positioning of the target tumor. Moreover, the 
combined use of these navigation technologies would make it 
easier to detect small or missing liver tumors. To our knowledge, 
the laparoscopic system for RVS is not yet available for commer-
cial use. Recently, laparoscopic liver resections have been widely 
applied for liver metastases. The laparoscopic system for RVS-
CEUS could be extremely useful for the detection of tumors when 
performing this surgery, since laparoscopic liver resection is 
limited to manipulating instruments and surgical space rather 
than being an open liver resection.
In conclusion, this study indicated that intraoperative RVS 
with Sonazoid enhancement was useful for detecting small met-
astatic liver lesions after chemotherapy and is a viable option for 
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